Phase Ⅱ Trial of Neoadjuvant Chemotherapy Combined With Camrelizumab Followed by Chemoradiotherapy in Patients Without Distant Metastasis Nasopharyngeal Carcinoma
Latest Information Update: 05 Mar 2021
At a glance
- Drugs Camrelizumab (Primary) ; Cisplatin; Docetaxel
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 05 Mar 2021 New trial record